<SEC-DOCUMENT>0001193125-25-064324-index.html : 20250327
<SEC-HEADER>0001193125-25-064324.hdr.sgml : 20250327
<ACCEPTANCE-DATETIME>20250327063940
ACCESSION NUMBER:		0001193125-25-064324
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20250327
DATE AS OF CHANGE:		20250327
EFFECTIVENESS DATE:		20250327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Compass Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001738021
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286148
		FILM NUMBER:		25775158

	BUSINESS ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135
		BUSINESS PHONE:		617-500-8099

	MAIL ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Olivia Ventures, Inc.
		DATE OF NAME CHANGE:	20180419
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d921736ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d921736ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d921736dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d921736dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d921736dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d921736dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d921736dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d921736dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g921736g10s57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g921736g10s57.jpg

</DOCUMENT>
</SEC-DOCUMENT>